Board Meeting5 May 2026, 10:21 pm
Pfizer Ltd Board Meeting Scheduled for May 12, 2026
AI Summary
Pfizer Ltd has announced a Board of Directors meeting scheduled for May 12, 2026, to consider and approve the financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend, if any, for the financial year ended March 31, 2026. The trading window for dealing in the company's shares has been closed from March 31, 2026, until 48 hours after the financial results are made public.
Key Highlights
- Pfizer board to approve FY26 financial results on May 12, 2026.
- Dividend recommendation to be considered at the board meeting.
- Trading window closed from March 31, 2026, until 48 hours post results.
Price Impact
More from PFIZER